S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

ZTO Express Posts 50% Profit Jump Amid Parcel Volume Growth

China's ZTO Express reported an adjusted net income of RMB3.1 billion for the second quarter of 2026, a 50.3% increase year-over-year. The company handled 10.5 billion parcels during the period, successfully expanding its market share to 19.9% while navigating a competitive landscape defined by shifting e-commerce dynamics.

ZTO Express Posts 50% Profit Jump Amid Parcel Volume Growth
Photo: Bio & News

Revenue for the quarter climbed 23% to RMB14.55 billion, bolstered by a 15.5% rise in parcel unit prices and a 6.5% increase in total volume. Management noted that the growth was largely driven by a surge in high-value key-account volumes, specifically in the reverse-logistics sector. Despite ongoing cost pressures from oil-price volatility, the company reduced its combined unit sorting and transportation costs by 2 cents through lean operations and increased automation.

ZTO’s leadership remains cautious regarding the broader economic climate, prompting an update to its full-year parcel volume growth guidance to a range of 6% to 10%. To bolster investor returns, the company has actively pursued a share repurchase program, utilizing US$740 million in 2026 to buy back over 31 million Class A shares. Looking ahead, the firm is strengthening its governance with the appointment of Wei Zhu, a veteran in management consulting and investment banking, to its board of directors effective August 19.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!